India, May 22 -- The Government of India has issued a release:
Schedule H1 Prescription Drug-CAUTION:
-It is dangerous to take this preparation except in accordance with the medical advice.
-Not to be sold by retail without the prescription of a Registered Medical Practitioner.
The Union Ministry of Health and Family Welfare has notified the inclusion of the drug "Pregabalin" under Schedule H1 of the Drugs Rules, 1945 vide Gazette Notification G.S.R. 377(E) dated 13th May 2026, published in the Gazette of India Extraordinary on 20th May 2026.
The decision has been taken in view of reports received from certain States regarding the misuse and abuse of Pregabalin, particularly among youth. The drug, which is prescribed for the treatment ...